Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunothera...
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
About this item
Full title
Author / Creator
Reustle, Anna , Di Marco, Moreno , Meyerhoff, Carolin , Nelde, Annika , Walz, Juliane S , Winter, Stefan , Kandabarau, Siahei , Büttner, Florian , Haag, Mathias , Backert, Linus , Kowalewski, Daniel J , Rausch, Steffen , Hennenlotter, Jörg , Stühler, Viktoria , Scharpf, Marcus , Fend, Falko , Stenzl, Arnulf , Rammensee, Hans-Georg , Bedke, Jens , Stevanović, Stefan , Schwab, Matthias and Schaeffeler, Elke
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Clear cell renal cell carcinoma (ccRCC) is the dominant subtype of renal cancer. With currently available therapies, cure of advanced and metastatic ccRCC is achieved only in rare cases. Here, we developed a workflow integrating different -omics technologies to identify ccRCC-specific HLA-presented peptides as potential drug targets for ccRCC immun...
Alternative Titles
Full title
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Authors, Artists and Contributors
Author / Creator
Di Marco, Moreno
Meyerhoff, Carolin
Nelde, Annika
Walz, Juliane S
Winter, Stefan
Kandabarau, Siahei
Büttner, Florian
Haag, Mathias
Backert, Linus
Kowalewski, Daniel J
Rausch, Steffen
Hennenlotter, Jörg
Stühler, Viktoria
Scharpf, Marcus
Fend, Falko
Stenzl, Arnulf
Rammensee, Hans-Georg
Bedke, Jens
Stevanović, Stefan
Schwab, Matthias
Schaeffeler, Elke
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_fc55be784afc4fe685c251765eeb65fb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fc55be784afc4fe685c251765eeb65fb
Other Identifiers
ISSN
1756-994X
E-ISSN
1756-994X
DOI
10.1186/s13073-020-00731-8
